|
1
|
Sena CM, Pereira AM and Seiça R:
Endothelial dysfunction - a major mediator of diabetic vascular
disease. Biochim Biophys Acta. 1832:2216–2231. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hirase T and Node K: Endothelial
dysfunction as a cellular mechanism for vascular failure. Am J
Physiol Heart Circ Physiol. 302:H499–H505. 2012. View Article : Google Scholar
|
|
3
|
Hu CH, Ke X, Chen K, Yang DY, Du ZM and Wu
GF: Transplantation of human umbilical cord-derived endothelial
progenitor cells promotes re-endothelialization of the injured
carotid artery after balloon injury in New Zealand white rabbits.
Chin Med J (Engl). 126:1480–1485. 2013.
|
|
4
|
Balaji S, King A, Crombleholme TM and
Keswani SG: The role of endothelial progenitor cells in postnatal
vasculogenesis: Implications for therapeutic neovascularization and
wound healing. Adv Wound Care (New Rochelle). 2:283–295. 2013.
View Article : Google Scholar
|
|
5
|
Zhang M, Malik AB and Rehman J:
Endothelial progenitor cells and vascular repair. Curr Opin
Hematol. 21:224–228. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu J, Wang Q, Wang H, Lu W, Li W, Qin Z
and Huang L: Activation of liver X receptor enhances the
proliferation and migration of endothelial progenitor cells and
promotes vascular repair through PI3K/Akt/eNOS signaling pathway
activation. Vascul Pharmacol. 62:150–161. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dudley AC, Cloer EW and Melero-Martin JM:
The role of bone marrow-derived progenitor cells in tumor growth
and angiogenesis. Stem Cells and Cancer Stem Cells. 8. Springer;
pp. 45–54. 2012, View Article : Google Scholar
|
|
8
|
Hibbert B, Ma X, Pourdjabbar A, Holm E,
Rayner K, Chen YX, Sun J, Filion L and O'Brien ER: Inhibition of
endothelial progenitor cell glycogen synthase kinase-3β results in
attenuated neointima formation and enhanced re-endothelialization
after arterial injury. Cardiovasc Res. 83:16–23. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Norton JD: ID helix-loop-helix proteins in
cell growth, differentiation and tumorigenesis. J Cell Sci.
113:3897–3905. 2000.PubMed/NCBI
|
|
10
|
Tanaka A, Itoh F, Itoh S and Kato M:
TAL1/SCL relieves the E2-2-mediated repression of VEGFR2 promoter
activity. J Biochem. 145:129–135. 2009. View Article : Google Scholar
|
|
11
|
Benezra R, Rafii S and Lyden D: The Id
proteins and angiogenesis. Oncogene. 20:8334–8341. 2001. View Article : Google Scholar
|
|
12
|
Lyden D, Young AZ, Zagzag D, Yan W, Gerald
W, O'Reilly R, Bader BL, Hynes RO, Zhuang Y, Manova K and Benezra
R: Id1 and Id3 are required for neurogenesis, angiogenesis and
vascularization of tumour xenografts. Nature. 401:670–677. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Valdimarsdottir G, Goumans M-J, Rosendahl
A, Brugman M, Itoh S, Lebrin F, Sideras P and ten Dijke P:
Stimulation of Id1 expression by bone morphogenetic protein is
sufficient and necessary for bone morphogenetic protein-induced
activation of endothelial cells. Circulation. 106:2263–2270. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ling M-T, Lau TC, Zhou C, Chua CW, Kwok
WK, Wang Q, Wang X and Wong YC: Overexpression of Id-1 in prostate
cancer cells promotes angiogenesis through the activation of
vascular endothelial growth factor (VEGF). Carcinogenesis.
26:1668–1676. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang H, Yu Y, Guo RW, Shi YK, Song MB,
Chen JF, Yu SY, Yin YG, Gao P and Huang L: Inhibitor of DNA
binding-1 promotes the migration and proliferation of endothelial
progenitor cells in vitro. Mol Cell Biochem. 335:19–27. 2010.
View Article : Google Scholar
|
|
16
|
Su Y, Gao L, Teng L, Wang Y, Cui J, Peng S
and Fu S: Id1 enhances human ovarian cancer endothelial progenitor
cell angiogenesis via PI3K/Akt and NF-κB/MMP-2 signaling pathways.
J Transl Med. 11:1322013. View Article : Google Scholar
|
|
17
|
Itoh F, Itoh S, Goumans MJ,
Valdimarsdottir G, Iso T, Dotto GP, Hamamori Y, Kedes L, Kato M and
ten Dijke Pt P: Synergy and antagonism between Notch and BMP
receptor signaling pathways in endothelial cells. EMBO J.
23:541–551. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tanaka A, Itoh F, Nishiyama K, Takezawa T,
Kurihara H, Itoh S and Kato M: Inhibition of endothelial cell
activation by bHLH protein E2-2 and its impairment of angiogenesis.
Blood. 115:4138–4147. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
20
|
Yang W, Itoh F, Ohya H, Kishimoto F,
Tanaka A, Nakano N, Itoh S and Kato M: Interference of
E2-2-mediated effect in endothelial cells by FAM96B through its
limited expression of E2-2. Cancer Sci. 102:1808–1814. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Von Offenberg Sweeney N, Cummins PM,
Cotter EJ, Fitzpatrick PA, Birney YA, Redmond EM and Cahill PA:
Cyclic strain-mediated regulation of vascular endothelial cell
migration and tube formation. Biochem Biophys Res Commun.
329:573–582. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cai H and Harrison DG: Endothelial
dysfunction in cardiovascular diseases: The role of oxidant stress.
Circ Res. 87:840–844. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pearson JD: Endothelial progenitor cells -
hype or hope? J Thromb Haemost. 7:255–262. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vasa M, Fichtlscherer S, Aicher A, Adler
K, Urbich C, Martin H, Zeiher AM and Dimmeler S: Number and
migratory activity of circulating endothelial progenitor cells
inversely correlate with risk factors for coronary artery disease.
Circ Res. 89:E1–E7. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Asahara T, Masuda H, Takahashi T, Kalka C,
Pastore C, Silver M, Kearne M, Magner M and Isner JM: Bone marrow
origin of endothelial progenitor cells responsible for postnatal
vasculogenesis in physiological and pathological
neovascularization. Circ Res. 85:221–228. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Takahashi T, Kalka C, Masuda H, Chen D,
Silver M, Kearney M, Magner M, Isner JM and Asahara T: Ischemia-
and cytokine-induced mobilization of bone marrow-derived
endothelial progenitor cells for neovascularization. Nat Med.
5:434–438. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
He T, Smith LA, Harrington S, Nath KA,
Caplice NM and Katusic ZS: Transplantation of circulating
endothelial progenitor cells restores endothelial function of
denuded rabbit carotid arteries. Stroke. 35:2378–2384. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Walter DH, Rittig K, Bahlmann FH,
Kirchmair R, Silver M, Murayama T, Nishimura H, Losordo DW, Asahara
T and Isner JM: Statin therapy accelerates reendothelialization: A
novel effect involving mobilization and incorporation of bone
marrow-derived endothelial progenitor cells. Circulation.
105:3017–3024. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Flora A, Garcia JJ, Thaller C and Zoghbi
HY: The E-protein Tcf4 interacts with Math1 to regulate
differentiation of a specific subset of neuronal progenitors. Proc
Natl Acad Sci USA. 104:15382–15387. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Q, Lu PH, Shi ZF, Xu YJ, Xiang J,
Wang YX, Deng LX, Xie P, Yin Y and Zhang B: Glucocorticoid receptor
β acts as a co-activator of T-cell factor 4 and enhances glioma
cell proliferation. Mol Neurobiol. 52:1–13. 2014.
|
|
31
|
Forrest MP, Hill MJ, Quantock AJ,
Martin-Rendon E and Blake DJ: The emerging roles of TCF4 in disease
and development. Trends Mol Med. 20:322–331. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ciarapica R, Annibali D, Raimondi L,
Savino M, Nasi S and Rota R: Targeting Id protein interactions by
an engineered HLH domain induces human neuroblastoma cell
differentiation. Oncogene. 28:1881–1891. 2009. View Article : Google Scholar : PubMed/NCBI
|
